CAS: 288392-69-8 - Siplizumab
Formula:Unspecified
- Synonyms:
- Immunoglobulin G1, anti-(human CD2 (antigen)) (human-rat monoclonal MEDI-507 γ1-chain), disulfide with human-rat monoclonal MEDI-507 light chain, dimer
- MEDI 507
- Siplizumab
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Siplizumab REF: TM-T77170CAS: 288392-69-8 | 95% - SDS-PAGE:95% SEC-HPLC:99.99% | 206.00 €~917.00 € | Fri 11 Oct 24 |
 | Siplizumab REF: 3D-CLA1070CAS: 288392-69-8 | - - - | To inquire | Mon 21 Oct 24 |
Siplizumab
CAS:288392-69-8
Siplizumab (MEDI-507), an IgG1 antibody targeting CD2, depletes T cells, may treat psoriasis.
Purity:
95% - SDS-PAGE:95% SEC-HPLC:99.99%
Color and Shape:
Solid
Ref: TM-T77170
| 1mg | 206.00 € | ||
| 5mg | 601.00 € | ||
| 10mg | 917.00 € |
Estimated delivery in United States, on Friday 11 Oct 2024
Siplizumab
CAS:288392-69-8
Anti-CD2 monoclonal antibody, potential psoriasis treatment, immunomodulatory effects
Ref: 3D-CLA1070
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 21 Oct 2024
